A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
| Status: | Archived |
|---|---|
| Conditions: | Neurology |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | February 2011 |
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
This is a Phase 2 randomized, double-blind, placebo-controlled, multicenter study of NP001
in subjects with ALS.
This is a randomized, double-blind, placebo-controlled study of NP001 in subjects with ALS
conducted in multiple centers. Drug or placebo will be given intravenously. Approximately
105 subjects will be enrolled. Subjects will be allocated (1:1:1) to placebo and 2 dose
levels of NP001.
We found this trial at
14
sites
California Pacific Medical Center California Pacific Medical Center is one of the largest private, not-for-profit,...
Click here to add this to my saved trials
Click here to add this to my saved trials
Cleveland Clinic Florida Cleveland Clinic Florida, located in Weston, West Palm Beach, Palm Beach Gardens...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
10833 Le Conte Ave
Los Angeles, California 90095
Los Angeles, California 90095
(310) 825-4321
David Geffen School of Medicine, UCLA In 2002 Mr. David Geffen announced a $200 million...
Click here to add this to my saved trials
Columbia Presbyterian Med Ctr On January 1, 1998, The New York Hospital publicly announced its...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Mayo Clinic Scottsdale Mayo Clinic Arizona was the second Mayo practice to be established outside...
Click here to add this to my saved trials